美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

知臨集團

9.29

+0.45665.17%

成交量：16.58萬

成交額：142.73萬

市值：756.28萬

市盈率：-5.01

高：10.02

開：7.75

低：7.04

收：8.83

52周最高：44.70

52周最低：6.00

股本：81.44萬

流通股本：53.59萬

量比：1.06

換手率：30.95%

股息：- -

股息率：- -

每股收益(TTM):-1.8543

每股收益(LYR):-1.8543

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):-5.01

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

知臨集團

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.aptorumgroup.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

知臨集團前身為APTUS Holdings Limited及STRIKER ASIA OPPORTUNITIES FUND CORPORATION，於2010年9月13日根據開曼群島法律註冊成立為有限公司。該公司是一家臨床階段的生物製藥公司，致力於發現、開發和商業化治療資產，以治療醫療需求未得到滿足的疾病，特別是在腫瘤學（包括孤兒腫瘤學適應症）和傳染病方面。Aptorum的產品線還通過以下方式得到充實：（i）建立藥物發現平台，以便通過以下方式發現新的治療資產：對現有已獲批準的藥物分子進行系統篩選，以及基於微生物組的代謝性疾病治療研究平台；（ii）與新加坡科學、技術和研究局的商業化部門Accelerate Technologies Pte Ltd共同開發PathsDx Test，這是一種新型的基於分子的快速病原體識別和檢測診斷技術。

董事

名稱

職位

Ian Huen

Chairman and Chief Executive Officer and Director

Douglas Arner

Independent Non-Executive Director

Justin Wu

Independent Non-Executive Director

Kira Sheinerman

Executive Director and Secretary and Treasurer

Laura A. Philips

Independent Non-Executive Director

股東

名稱

職位

Ian Huen

Chairman and Chief Executive Officer and Director

Gary Anthony

Chief Financial Officer

Alidad Mireskandari

Chief Operation Officer and President

Kira Sheinerman

Executive Director and Secretary and Treasurer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NIKI/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NIKI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NIKI\",,,,,undefined,":{"symbol":"NIKI","market":"US","secType":"STK","nameCN":"知臨集團","latestPrice":9.2866,"timestamp":1784658407061,"preClose":8.83,"halted":0,"volume":165849,"delay":0,"changeRate":0.051710079275198176,"floatShares":535929,"shares":814380,"eps":-1.85433,"marketStatus":"交易中","change":0.4566,"latestTime":"07-21 14:26:52 EDT","open":7.75,"high":10.02,"low":7.04,"amount":1427347.575492,"amplitude":0.337486,"askPrice":9.37,"askSize":1,"bidPrice":9.2,"bidSize":67,"shortable":0,"etf":0,"ttmEps":-1.85433,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1784664000000},"marketStatusCode":2,"adr":0,"listingDate":1545195600000,"exchange":"NASDAQ","adjPreClose":8.83,"preHourTrading":{"tag":"盘前","latestPrice":7.9,"preClose":8.83,"latestTime":"09:28 EDT","volume":6043,"amount":47449.2625426,"timestamp":1784640484500,"change":-0.93,"changeRate":-0.105323,"amplitude":0.13137},"postHourTrading":{"tag":"盘后","latestPrice":7.81,"preClose":8.83,"latestTime":"19:59 EDT","volume":42960,"amount":350007.9525,"timestamp":1784591967077,"change":-1.02,"changeRate":-0.115515,"amplitude":0.157418},"volumeRatio":1.055034},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NIKI\",,,,,undefined,":{"symbol":"NIKI","floatShares":535929,"roa":"--","roe":"--","lyrEps":-1.85433,"volumeRatio":1.055034,"shares":814380,"dividePrice":0,"high":10.02,"amplitude":0.337486,"preClose":8.83,"low":7.04,"week52Low":6,"pbRate":"--","week52High":44.7,"institutionHeld":0,"latestPrice":9.2866,"committee":0.970588,"eps":-1.85433,"divideRate":0,"volume":165849,"delay":0,"ttmEps":-1.85433,"open":7.75,"prevYearClose":10.6,"prevWeekClose":7,"prevMonthClose":7.822,"prevQuarterClose":7.822,"fiveDayClose":8.148,"twentyDayClose":8.582,"sixtyDayClose":9.185},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NIKI\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NIKI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NIKI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.aptorumgroup.com","compareEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":0.0031},{"period":"3month","weight":0.0467},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1835},{"period":"ytd","weight":0.09}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"知臨集團前身為APTUS Holdings Limited及STRIKER ASIA OPPORTUNITIES FUND CORPORATION，於2010年9月13日根據開曼群島法律註冊成立為有限公司。該公司是一家臨床階段的生物製藥公司，致力於發現、開發和商業化治療資產，以治療醫療需求未得到滿足的疾病，特別是在腫瘤學（包括孤兒腫瘤學適應症）和傳染病方面。Aptorum的產品線還通過以下方式得到充實：（i）建立藥物發現平台，以便通過以下方式發現新的治療資產：對現有已獲批準的藥物分子進行系統篩選，以及基於微生物組的代謝性疾病治療研究平台；（ii）與新加坡科學、技術和研究局的商業化部門Accelerate Technologies Pte Ltd共同開發PathsDx Test，這是一種新型的基於分子的快速病原體識別和檢測診斷技術。","exchange":"NASDAQ","name":"知臨集團","nameEN":"Aptorum Group Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NIKI\",market:\"US\",,,undefined,":{"directors":[{"name":"Ian Huen","position":"Chairman and Chief Executive Officer and Director"},{"name":"Douglas Arner","position":"Independent Non-Executive Director"},{"name":"Justin Wu","position":"Independent Non-Executive Director"},{"name":"Kira Sheinerman","position":"Executive Director and Secretary and Treasurer"},{"name":"Laura A. Philips","position":"Independent Non-Executive Director"}],"executives":[{"name":"Ian Huen","position":"Chairman and Chief Executive Officer and Director"},{"name":"Gary Anthony","position":"Chief Financial Officer"},{"name":"Alidad Mireskandari","position":"Chief Operation Officer and President"},{"name":"Kira Sheinerman","position":"Executive Director and Secretary and Treasurer"}]}}}